Sandbox 9888: Difference between revisions

Line 22:

In determining the proper amount of how much of the drug should be injected, Remicade is able to sufficiently block TNF-α from interacting with the TNF receptors (TNFR) <ref name="wong"/>. Thus, inhibiting the receptor from signaling production of IL-1 and IL-6, both of which are pro-inflammatory cytokines <ref>PMID:27100432</ref>. When this occurs, Remicade acts as a competitive inhibitor of TNF-R. If an adequate amount of Remicade, or other competitive inhibitor, is introduced the TNF-α binding interface will be obstructed, thus preventing TNF-α from participating further in diseases.

Once the complex forms, it is stabilized by the amino acid residues <scene name='74/744162/Cdef_residues/1'>Gln67–His73 and Gln102–Lys112</scene> of the C-D and E-F loops <ref name="liang"/>. Particularly, the weak interactions between the loops and side chains, allows for a stronger binding affinity. The strongest interaction between the two proteins is best seen in the peak region of TNF. This arises when TNF-α is in its active form and exists as a trimer <ref name="liang"/>. Although, research has offered some insight into the mechanisms of how Remicade effectively inhibits TNF-α, studies have not shown a clear understanding of the extensive underlying network. Thus, more research into this matter should be pursued.

Once the complex forms, it is stabilized by the amino acid residues <scene name='74/744162/Cdef_residues/2'>Gln67–His73 and Gln102–Lys112</scene> of the C-D and E-F loops <ref name="liang"/>. Particularly, the weak interactions between the loops and side chains, allows for a stronger binding affinity. The strongest interaction between the two proteins is best seen in the peak region of TNF. This arises when TNF-α is in its active form and exists as a trimer <ref name="liang"/>. Although, research has offered some insight into the mechanisms of how Remicade effectively inhibits TNF-α, studies have not shown a clear understanding of the extensive underlying network. Thus, more research into this matter should be pursued.

== Diseases ==

Sandbox 9888: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 22: / Line 22: @@
 In determining the proper amount of how much of the drug should be injected, Remicade is able to sufficiently block TNF-α from interacting with the TNF receptors (TNFR) <ref name="wong"/>. Thus, inhibiting the receptor from signaling production of IL-1 and IL-6, both of which are pro-inflammatory cytokines <ref>PMID:27100432</ref>. When this occurs, Remicade acts as a competitive inhibitor of TNF-R. If an adequate amount of Remicade, or other competitive inhibitor, is introduced the TNF-α binding interface will be obstructed, thus preventing TNF-α from participating further in diseases.
-Once the complex forms, it is stabilized by the amino acid residues <scene name='74/744162/Cdef_residues/1'>Gln67–His73 and Gln102–Lys112</scene> of the C-D and E-F loops <ref name="liang"/>. Particularly, the weak interactions between the loops and side chains, allows for a stronger binding affinity. The strongest interaction between the two proteins is best seen in the peak region of TNF. This arises when TNF-α is in its active form and exists as a trimer <ref name="liang"/>. Although, research has offered some insight into the mechanisms of how Remicade effectively inhibits TNF-α, studies have not shown a clear understanding of the extensive underlying network. Thus, more research into this matter should be pursued.
+Once the complex forms, it is stabilized by the amino acid residues <scene name='74/744162/Cdef_residues/2'>Gln67–His73 and Gln102–Lys112</scene> of the C-D and E-F loops <ref name="liang"/>. Particularly, the weak interactions between the loops and side chains, allows for a stronger binding affinity. The strongest interaction between the two proteins is best seen in the peak region of TNF. This arises when TNF-α is in its active form and exists as a trimer <ref name="liang"/>. Although, research has offered some insight into the mechanisms of how Remicade effectively inhibits TNF-α, studies have not shown a clear understanding of the extensive underlying network. Thus, more research into this matter should be pursued.
 == Diseases ==